Skip to content
Clinical Trials – home
Istituto Di Ricerche Farmacologiche Mario Negri
Sponsor

Istituto Di Ricerche Farmacologiche Mario Negri

Italy Via Gian Battista Camozzi 3, 24020 Ranica, Italy

About the sponsor

Research activity centers on membranous nephropathy, primary membranous nephropathy, and idiopathic nephrotic syndrome, with additional work in end-stage kidney disease on chronic dialysis therapy and chronic kidney disease complicated by hyperkalemia.

  • Nephrotic syndrome
  • Anti-CD20-resistant kidney disease
  • Potassium management in CKD and dialysis

These studies include treatment strategies for proteinuria, relapse prevention, and electrolyte control in advanced renal disease.

About Specializations

Istituto Di Ricerche Farmacologiche Mario Negri runs clinical trials in conditions such as Glomerulonephritis membranous, Nephrotic syndrome, End stage renal disease, Dialysis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

10 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Patiromer
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:ACETYLCARNITINE HYDROCHLORIDE
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Argon
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ceralasertib
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Aminohippuric Acid
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri

Hyperkalaemia

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.